These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25813871)

  • 1. Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review.
    Amengual O; Fujita D; Ota E; Carmona L; Oku K; Sugiura-Ogasawara M; Murashima A; Atsumi T
    Lupus; 2015 Oct; 24(11):1135-42. PubMed ID: 25813871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
    Front Immunol; 2019; 10():1948. PubMed ID: 31475009
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
    Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
    Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis.
    Frishman M; Radin M; Schreiber K
    Curr Opin Obstet Gynecol; 2020 Oct; 32(5):351-358. PubMed ID: 32675702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.
    Mekinian A; Bourrienne MC; Carbillon L; Benbara A; Noémie A; Chollet-Martin S; Tigaizin A; Montestruc F; Fain O; Nicaise-Roland P
    Semin Arthritis Rheum; 2016 Oct; 46(2):232-237. PubMed ID: 27432776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    Sciascia S; Hunt BJ; Talavera-Garcia E; Lliso G; Khamashta MA; Cuadrado MJ
    Am J Obstet Gynecol; 2016 Feb; 214(2):273.e1-273.e8. PubMed ID: 26429521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes.
    Tanacan A; Beksac MS; Orgul G; Duru S; Sener B; Karaagaoglu E
    Hum Antibodies; 2019; 27(2):135-141. PubMed ID: 30856108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological evolution in women with positive antiphospholipid antibodies.
    Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
    Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
    Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
    Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of miscarriage in antiphospholipid syndrome.
    Passaleva A; Massai G; D'Elios MM; Livi C; Abbate R
    Autoimmunity; 1992; 14(2):121-5. PubMed ID: 1303678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
    Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
    J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous pseudovasculitis, antiphospholipid syndrome and obstetric misadventure.
    Thayaparan AS; Lowe SA
    Lupus; 2015 Sep; 24(10):1107-10. PubMed ID: 25748061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
    Fischer-Betz R; Specker C; Brinks R; Schneider M
    Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies.
    Out HJ; Bruinse HW; Christiaens GC; van Vliet M; de Groot PG; Nieuwenhuis HK; Derksen RH
    Am J Obstet Gynecol; 1992 Jul; 167(1):26-32. PubMed ID: 1442938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.